To access the results of clinical trials, researchers use “endpoints,” specific events or outcomes that help evaluate the benefit of the intervention under investigation. Traditionally, overall ...

Oligometastatic cancer, a specific type of metastasis that occurs when cancer cells from a primary tumor travel within the body and form new tumors in one or two distant parts of the body. Treatment ...

The US Food and Drug Administration (FDA) on Thursday released draft guidance for industry on the problems posed by multiple endpoints in the analysis and interpretation of study results and how these ...

Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

Biopharmaceutical heavyweights – from Novartis to GlaxoSmithKline to Regeneron – are seeking additional clarification from the US Food and Drug Administration (FDA) on draft guidance on multiple ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, ...

Less than half of the recent trials testing therapies for atherosclerotic cardiovascular disease (ASCVD) use the same endpoint, and many alter those endpoints after enrollment begins, according to a ...

Please provide your email address to receive an email when new articles are posted on . Topline results from the phase 3 ReThink-ALZ study of simufilam in mild to moderate Alzheimer’s disease showed ...

An international group of experts led by the Comprehensive Cancer Centre (CCC) at MedUni Vienna and University Hospital Vienna has established endpoints for clinical trials in patients with cancer and ...

(RTTNews) - Akeso Inc. reported positive results from Phase 3 clinical trial of gumokimab or AK111, a fully human anti-IL-17A monoclonal antibody, for the treatment of active ankylosing spondylitis.